Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000457902 | SCV000563758 | likely benign | Gastrointestinal stromal tumor; Paragangliomas 4; Pheochromocytoma | 2024-01-30 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000563461 | SCV000675064 | benign | Hereditary cancer-predisposing syndrome | 2020-03-30 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Gene |
RCV000604153 | SCV000732854 | likely benign | not specified | 2018-01-15 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
ARUP Laboratories, |
RCV001810969 | SCV001477865 | likely benign | not provided | 2020-02-18 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV000563461 | SCV002527068 | likely benign | Hereditary cancer-predisposing syndrome | 2021-03-19 | criteria provided, single submitter | curation |